An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate the safety and efficacy of intravenous recombinant tissue Plasminogen
Activator, alteplase, Actilyse® (rt-PA) (0.9 mg/kg) within 3 hours of symptom onset in acute
ischemic stroke